-+ 0.00%
-+ 0.00%
-+ 0.00%
Zimmer Biomet CEO Says Says Excluding Impact Of China Distributor Network Consolidation, Q3 Constant-Currency Sales Growth Would Have Been 4.4%; Global Knees Sales Would Have Been Flat YoY In Q3 Excluding China Headwinds; Expects To File Monogram 510(K) Application With FDA Very Soon, Ahead Of Schedule; China-Related Headwinds Will Anniversary In January 2027, Improving Visibility Into Knees Performance
Share
Listen to the news

-Conference Call. 

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending